Document is current

Any future updates will be listed below

653 APN401, a novel EPiC-based anti-cancer cell therapy, case report: Cbl-b silenced, autologous PBMCs induced stable disease in an appendix carcinoma patient

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.0653

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark